Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 1, 2005, Pages 227-233

  Braekke, Kristin ^a   Holthe, Mette R ^a   Harsem, Nina Kittelsen ^a   Fagerhol, Magne K ^a   Staff, Anne Cathrine ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Calprotectin; CRP; Fetal; PAI 1 (plasminogen activator inhibitor type 1); Preeclampsia

Indexed keywords

C REACTIVE PROTEIN; CALPROTECTIN; MARKER; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; BLOOD LEVEL; CESAREAN SECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS; FETUS BLOOD; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATERNAL PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; AMNIOTIC FLUID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CESAREAN SECTION; FEMALE; FETAL BLOOD; HUMANS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; OSMOLAR CONCENTRATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY;

EID: 22244455757     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.11.055     Document Type: Article

References (27)

1. M.K. Fagerhol, I. Dale, and I. Anderson Release and quantification of leukocyte derived protein (L1) Scand J Haematol 24 1980 393 398
2. B. Johne, M.K. Fagerhol, T. Lyberg, H. Prydz, P. Brandtzaeg, and C.F. Naess-Andresen Functional and clinical aspects of the myelomonocyte protein calprotectin Scand J Clin Lab Invest 50 1997 113 123
3. S. Yui, Y. Nakatani, and M. Mikami Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity Biol Pharm Bull 26 2003 753 760
4. C.W. Redman, G.P. Sacks, and I.L. Sargent Preeclampsia: an excessive maternal inflammatory response to pregnancy Am J Obstet Gynecol 180 1999 499 506
5. J.M. Roberts, and K.Y. Lain Recent insights into the pathogenesis of pre-eclampsia Placenta 23 2002 359 372
6. H. Kato, Y. Yoneyama, and T. Araki Fetal plasma lipid peroxide levels in pregnancies complicated by preeclampsia Gynecol Obstet Invest 43 1997 158 161
7. S.T. Davidge, A.P. Signorella, D.L. Lykins, C.H. Gilmour, and J.M. Roberts Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women Am J Obstet Gynecol 175 1996 1301 1306
8. S.A. Friedman, E. Schiff, J.J. Emeis, G.A. Dekker, L. Kao, and B.M. Sibai Fetal plasma levels of cellular fibronectin as a measure of fetal endothelial involvement in preeclampsia Obstet Gynecol 89 1997 46 48
9. M.J. Kupferminc, A.M. Peaceman, S. Dollberg, and M.L. Socol Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia Am J Perinatol 16 1999 203 208
10. E.T. Yeh, and J.T. Willerson Coming of age of C-reactive protein: using inflammation markers in cardiology Circulation 107 2003 370 371
11. M. Wolf, E. Kettyle, L. Sandler, J.L. Ecker, J. Roberts, and R. Thadhani Obesity and preeclampsia: the potential role of inflammation Obstet Gynecol 98 2001 757 762
12. L. Belo, A. Santos-Silva, M. Caslake, J. Cooney, L. Pereira-Leite, and A. Quintanilha Neutrophil activation and C-reactive protein concentration in preeclampsia Hypertens Pregnancy 22 2003 129 141
13. A. Halligan, J. Bonnar, B. Sheppard, M. Darling, and J. Walshe Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia BJOG 101 1994 488 492
14. J. Kristinsson, A. Roseth, M.K. Fagerhol, E. Aadland, H. Schjonsby, and O.P. Bormer Fecal calprotectin concentration in patients with colorectal carcinoma Dis Colon Rectum 41 1998 316 321
15. N. Khuseyinova, A. Imhof, G. Trischler, D. Rothenbacher, W.L. Hutchinson, and M.B. Pepys Determination of C-reactive protein: comparison of three high-sensitivity immunoassays Clin Chem 49 2003 1691 1695
16. G.P. Sacks, K. Studena, K. Sargent, and C.W. Redman Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis Am J Obstet Gynecol 179 1998 80 86
17. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists Int J Gynaecol Obstet 77 2002 67 75
18. R. Carr Neutrophil production and function in newborn infants Br J Haematol 110 2000 18 28
19. M.A. Turner, S. Power, and A.J. Emmerson Gestational age and the C reactive protein response ArchDis Child Fetal Neonatal Ed 89 2004 F272 F273
20. K. Schibler Leukocyte development and disorders during the neonatal period R.D. Cristensen Hematologic problems of the neonate 2000 W.B. Saunders Company Philadelphia 311 342
21. J.R. Mellembakken, P. Aukrust, M.K. Olafsen, T. Ueland, K. Hestdal, and V. Videm Activation of leukocytes during the uteroplacental passage in preeclampsia Hypertension 39 2002 155 160
22. D.F. Benyo, A. Smarason, C.W. Redman, C. Sims, and K.P. Conrad Expression of inflammatory cytokines in placentas from women with preeclampsia J Clin Endocrinol Metab 86 2001 2505 2512
23. J. Espinoza, T. Chaiworapongsa, R. Romero, S. Edwin, C. Rathnasabapathy, and R. Gomez Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes J Matern Fetal Neonatal Med 13 2003 2 21
24. J.R. Woods Maternal and transplacental effects of cocaine Ann N Y Acad Sci 846 1998 1 11
25. C.W.G. Redman, and I.L. Sargent The pathogenesis of pre-eclampsia Gynecol Obstet Fertil 29 2001 518 522
26. K.H. Lim, Y. Zhou, M. Janatpour, M. McMaster, K. Bass, and S.H. Chun Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia Am J Pathol 151 1997 1809 1818
27. B. Isaksen, and M.K. Fagerhol Calprotectin inhibits matrix metalloproteinases by sequestration of zinc Scand J Clin Lab Invest 54 2001 289 292